efgartigimod
argenx
['vyvgart', 'argenx']
dutch #biotech reports data at #ash22 showing vyvgart could also be an effective treatment for #raredisease immune thrombocytopenia 
https://t.co/O0ZJQGuINh, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate